Background
1. Clinical trial requirements for FSMPs are similar to pharmaceutical requirements. 2. The government provides 13 broad categories of disorders as examples in which FSMPs may be of therapeutic benefit however products are not limited to these categories. 3. Difficulties in substantiating scientifically significant therapeutic/clinical benefit, trail size requirements and cost are major difficulties for successfully meeting China’s FSMP registration requirements.
Background